Patients are eager for new and better treatments, yet more than one-third of clinical trials do not meet their enrollment goals. Read more on how the federal government can improve clinical trials awareness: bit.ly/49XiZ6W

#DYK? 90% of medications administered to newborns are not approved by the @US_FDA for use in the newborn population. Learn more: bit.ly/3NcwFAp

Learn about overcoming financial barriers to clinical trials enrollment in this CCTA paper ▶️ bit.ly/3Er3wMj

Why Alzheimer's and Parkinson's patients need clinical trials awareness? Learn here: bit.ly/3ZSfJXx

DYK? Just 1 out of 3 cardiovascular trial participants are women. Cures begin with clinical trials awareness.

Only 1 out of 10 people with Parkinson's disease participate in a clinical trial. Cures begin with clinical trials awareness.

DYK? 40% of cancer trials don't meet minimum patient enrollment. Cures begin with clinical trials awareness.

Aging affects how people absorb, metabolize and excrete drugs. Yet clinical trials focus on participants aged 18-64. Seniors shouldn't miss out on clinical trials: bit.ly/3Vs0GA5

DYK? 90% of medications administered to newborns are not approved by the Food and Drug Administration for use in the newborn population. Learn more: bit.ly/3NcwFAp

Clinical trials offer treatment options for patients. But trial participation can present unexpected costs for these patients. Learn more: bit.ly/4evC2XB

Public awareness is the essential factor driving increased engagement in clinical trials, ultimately fostering innovation and addressing patients' health care needs. Learn more: bit.ly/3ZR2tlX

Clinical trials are an important step in the development of breakthrough treatments. But there’s a problem: Not enough people join clinical trials. Learn more: bit.ly/3Y9OK8q

DYK? Patients 65 and older tend to take more medication than other age groups, yet clinical trials focus on participants aged 18-64. Learn more ▶️ bit.ly/3Vs0GA5

Clinical trials can be costly, but there are solutions to help manage the financial burden. Learn more ▶️ bit.ly/4bilEXT

Aging affects how people absorb, metabolize and excrete drugs, yet clinical trials only focus on participants aged 18-64. Learn more ▶️ bit.ly/3Vs0GA5

DYK? 49% of Americans think low enrollment reflects lack of awareness. Learn more ▶️ bit.ly/3teZQbf

About one-third of clinical trials aimed at Parkinson's disease fail to start due to a shortage of participants. This insufficient enrollment can lead to a loss of potential innovative treatments for the disease. Learn more ▶️ bit.ly/3teZQbf

DYK? About 4 million babies are born each year in the United States, yet 90% of the medications they take have never been tested for children. Learn more why clinical trials need newborns ▶️ bit.ly/3Hbm46y

Clinical trials can have associated costs including parking, travel, child care or lost work income, which can be a serious deterrent to trial participation. Learn more ▶️ bit.ly/3Er3wMj

Clinical trials can have hidden costs for patients. Learn about them from David Charles, MD, in this episode of AfPA's Patient Access Podcast: bit.ly/3OLKMxV